What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
October, 20 2025
Join the discussion this Saturday, October 18, 2025, at the Hamburg Auditorium – CityCube A, to explore how AI is […]
News
October, 20 2025
Today, the PI of this #EuropeanProject, Arsela Prelaj, is moderating an Educational Session on AI-based image biomarkers in oncology, radiology […]
News
October, 13 2025
Discover how AI is transforming clinical trials in oncology! Artificial intelligence is revolutionizing how we design and conduct clinical trials […]